Cholesterol gallstone disease

[1]  A. Honda,et al.  Hepatic cholesterol and bile acid synthesis in Japanese patients with cholesterol gallstones , 1993, Gastroenterologia Japonica.

[2]  M. Boermeester,et al.  Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy , 2006, Hepatology.

[3]  C. la Vecchia,et al.  Gallbladder cancer worldwide: Geographical distribution and risk factors , 2006, International journal of cancer.

[4]  J. Fox,et al.  Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[5]  F. Lammert,et al.  Mechanisms of Disease: the genetic epidemiology of gallbladder stones , 2005, Nature Clinical Practice Gastroenterology &Hepatology.

[6]  F. Lammert,et al.  The genetic background of cholesterol gallstone formation: an inventory of human lithogenic genes. , 2005, Current drug targets. Immune, endocrine and metabolic disorders.

[7]  G. Paumgartner,et al.  Extracorporeal shock wave lithotripsy of gallstones: 20th anniversary of the first treatment , 2005, European journal of gastroenterology & hepatology.

[8]  E. Shaffer,et al.  Epidemiology and risk factors for gallstone disease: Has the paradigm changed in the 21st century? , 2005, Current gastroenterology reports.

[9]  M. Veysey,et al.  Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly , 2005, Gut.

[10]  J. Rehfeld,et al.  Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis , 2005, Hepatology.

[11]  J. Fox,et al.  Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. , 2005, Gastroenterology.

[12]  Lunan Zhang,et al.  High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice. , 2005, Biochimica et biophysica acta.

[13]  M. Goldacre,et al.  Cancer after cholecystectomy: record-linkage cohort study , 2005, British Journal of Cancer.

[14]  J. Behar,et al.  Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[15]  S. Grundy,et al.  The metabolic syndrome , 2003, The Lancet.

[16]  E. Dimagno,et al.  Relationships among canine fasting pancreatic and biliary secretions, pancreatic duct pressure, and duodenal phase III motor activity—Boldyreff revisited , 1979, Digestive Diseases and Sciences.

[17]  角田 和彦.  Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake , 2005 .

[18]  A. Bookout,et al.  Prevention of cholesterol gallstone disease by FXR agonists in a mouse model , 2004, Nature Medicine.

[19]  W. Willett,et al.  The Effect of Long-Term Intake of cis Unsaturated Fats on the Risk for Gallstone Disease in Men , 2004, Annals of Internal Medicine.

[20]  F. Schmitz,et al.  Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. , 2004, The Journal of clinical investigation.

[21]  S. Grundy.  Cholesterol gallstones: a fellow traveler with metabolic syndrome? , 2004, The American journal of clinical nutrition.

[22]  J. Miquel,et al.  Diet as a Risk Factor for Cholesterol Gallstone Disease , 2004, Journal of the American College of Nutrition.

[23]  R. Sandler,et al.  Digestive and liver diseases statistics, 2004. , 2004, Gastroenterology.

[24]  P. Portincasa,et al.  Smooth muscle function and dysfunction in gallbladder disease , 2004, Current gastroenterology reports.

[25]  N. Afdhal,et al.  Genetic analysis of cholesterol gallstone formation: Searching for Lith (gallstone) genes , 2004, Current gastroenterology reports.

[26]  M. Samsom,et al.  Interdigestive Gallbladder Emptying, Antroduodenal Motility, and Motilin Release Patterns Are Altered in Cholesterol Gallstone Patients , 2001, Digestive Diseases and Sciences.

[27]  F. Caroli-Bosc,et al.  Cholelithiasis and Dietary Risk Factors (An Epidemiologic Investigation in Vidauban, Southeast France) , 1998, Digestive Diseases and Sciences.

[28]  H. Ackermann,et al.  Dissolution of Gallbladder Stones with Methyl tert-Butyl Ether and Stone Recurrence (A European Survey) , 1998, Digestive Diseases and Sciences.

[29]  R. Blevins,et al.  Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3* , 2003, Journal of Biological Chemistry.

[30]  G. Calamita,et al.  Water handling and aquaporins in bile formation: recent advances and research trends. , 2003, Journal of hepatology.

[31]  P. Boelle,et al.  ABCB4 gene mutation-associated cholelithiasis in adults. , 2003, Gastroenterology.

[32]  P. Portincasa,et al.  Measurements of gallbladder motor function by ultrasonography: towards standardization. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[33]  S. Pereira,et al.  Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile , 2003, Alimentary pharmacology & therapeutics.

[34]  F. Lammert,et al.  Mouse models for genetic dissection of polygenic gastrointestinal diseases , 2003, European journal of clinical investigation.

[35]  Jonathan C. Cohen,et al.  Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Howard,et al.  Prevalence of gallbladder disease in American Indian populations: Findings from the Strong Heart Study , 2002, Hepatology.

[37]  H. Hobbs,et al.  Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors α and β* , 2002, The Journal of Biological Chemistry.

[38]  Clifford Goodman,et al.  The burden of selected digestive diseases in the United States. , 2002, Gastroenterology.

[39]  H. Hobbs,et al.  Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. , 2002, The Journal of biological chemistry.

[40]  C. Love,et al.  Diagnosis of acute cholecystitis: sensitivity of sonography, cholescintigraphy, and combined sonography-cholescintigraphy. , 2001, Journal of the American College of Surgeons.

[41]  A. Groen,et al.  Role of biliary proteins and non-protein factors in kinetics of cholesterol crystallisation and gallstone growth. , 2001, Frontiers in bioscience : a journal and virtual library.

[42]  F. Lammert,et al.  Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles. , 2001, Journal of hepatology.

[43]  M. Makishima,et al.  Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor* , 2001, The Journal of Biological Chemistry.

[44]  P. Portincasa,et al.  Cholesterol crystallization in model biles: effects of bile salt and phospholipid species composition. , 2001, Journal of lipid research.

[45]  O. Rosmorduc,et al.  MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. , 2001, Gastroenterology.

[46]  Zhe Zhang,et al.  Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations. , 2001, Journal of lipid research.

[47]  J. Rehfeld,et al.  Severe impairment of postprandial cholecystokinin release and gall‐bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR , 2001, Alimentary pharmacology & therapeutics.

[48]  N. Schork,et al.  Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. , 2000, Physiological genomics.

[49]  N. Smeeton,et al.  Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. , 2000, Gastroenterology.

[50]  P. Portincasa,et al.  Review article: agents affecting gall‐bladder motility – role in treatment and prevention of gallstones , 2000, Alimentary pharmacology & therapeutics.

[51]  D. Danino,et al.  Microstructural evolution of lipid aggregates in nucleating model and human biles visualized by cryogenic transmission electron microscopy , 2000, Hepatology.

[52]  A. Hofmann,et al.  The continuing importance of bile acids in liver and intestinal disease. , 1999, Archives of internal medicine.

[53]  J. Everhart,et al.  Prevalence and ethnic differences in gallbladder disease in the United States. , 1999, Gastroenterology.

[54]  N. Tanaka,et al.  Long‐term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: A cohort analysis , 1999, Hepatology.

[55]  A. Groen,et al.  Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. , 1999, Gastroenterology.

[56]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[57]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[58]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[59]  G. P. van Berge‐Henegouwen,et al.  Gallstones: an intestinal disease? , 1999, Gut.

[60]  K. V. van Erpecum,et al.  Gallstones: an intestinal disease? , 1999, Gut.

[61]  S. Lee,et al.  Biliary Sludge , 1999, Annals of Internal Medicine.

[62]  Tim Appenzeller,et al.  Evolution or Revolution? , 1998, Science.

[63]  J. Miquel,et al.  Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. , 1998, Gastroenterology.

[64]  E. Scafato,et al.  Diet and gallstones in italy: The cross‐sectional MICOL results , 1998, Hepatology.

[65]  P. Meier,et al.  The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver* , 1998, The Journal of Biological Chemistry.

[66]  Z. Shen,et al.  Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. , 1998, Gastroenterology.

[67]  A. Smith,et al.  Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy. , 1997, The Journal of clinical investigation.

[68]  A. Menotti,et al.  Factors associated with gallstone disease in the MICOL experience , 1997, Hepatology.

[69]  P. Hylemon,et al.  7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. , 1996, Gastroenterology.

[70]  M. Carey,et al.  Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences. , 1996, Journal of lipid research.

[71]  D. Mangelsdorf,et al.  An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.

[72]  S. Ketover,et al.  The role of gallbladder emptying in gallstone formation during diet‐induced rapid weight loss , 1996, Hepatology.

[73]  P. Portincasa,et al.  Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock‐wave lithotripsy , 1996, Hepatology.

[74]  G. Paumgartner,et al.  Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. , 1996, Gastroenterology.

[75]  M. Carey,et al.  Pathogenesis of cholesterol gallstones: a parsimonious hypothesis , 1996, European journal of clinical investigation.

[76]  P. Portincasa,et al.  Behavior of various cholesterol crystals in bile from patients with gallstones , 1996, Hepatology.

[77]  M. Carey,et al.  Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems. , 1996, Journal of lipid research.

[78]  B. Paigen,et al.  Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[79]  N. Tait,et al.  Fortnightly Review: The treatment of gall stones , 1995, BMJ.

[80]  S. Sarin,et al.  High familial prevalence of gallstones in the first‐degree relatives of gallstone patients , 1995, Hepatology.

[81]  N. Tanaka,et al.  Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit , 1995, Hepatology.

[82]  C. Wells,et al.  Re: "Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)". , 1995, American journal of epidemiology.

[83]  B. Schirmer,et al.  A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. , 1995, American journal of surgery.

[84]  A. Menotti,et al.  Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) , 1995, American journal of epidemiology.

[85]  G. Paumgartner,et al.  Ursodeoxycholic acid treatment of cholesterol gallstone disease. , 1994, Scandinavian journal of gastroenterology. Supplement.

[86]  P. Portincasa,et al.  Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. , 1994, Journal of hepatology.

[87]  T. Sauerbruch,et al.  Gallstone recurrence after shock-wave therapy. , 1994, Gastroenterology.

[88]  P. Borst,et al.  Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.

[89]  M. Kaplan,et al.  Pathogenesis and treatment of gallstones. , 1993, The New England journal of medicine.

[90]  G. Friedman.  Natural history of asymptomatic and symptomatic gallstones. , 1993, American journal of surgery.

[91]  K. V. van Erpecum,et al.  Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gallbladder emptying. , 1993, The American journal of physiology.

[92]  P. Emmett,et al.  An explanation for gallstones in normal-weight women: slow intestinal transit , 1993, The Lancet.

[93]  M. Kaplan,et al.  PATHOGENESIS AND TREATMENT OF GALLSTONES. AUTHOR'S REPLY , 1993 .

[94]  D. Small,et al.  Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile. Evidence that cholesterol does not nucleate classic monohydrate plates. , 1992, The Journal of clinical investigation.

[95]  D. Russell,et al.  Bile acid biosynthesis. , 1992, Biochemistry.

[96]  K. V. van Erpecum,et al.  Fasting gallbladder volume, postprandial emptying and cholecystokinin release in gallstone patients and normal subjects. , 1992, Journal of hepatology.

[97]  S. Lee,et al.  Biliary sludge as a cause of acute pancreatitis. , 1992, The New England journal of medicine.

[98]  M. Carey,et al.  Cholesterol gallstone formation. 2. Pathobiology and pathomechanics. , 1992, Progress in liver diseases.

[99]  C. Brú,et al.  Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. , 1991, Gastroenterology.

[100]  M. Radlauer.  Clinical evaluation for gallstone disease: Usefulness of symptoms and signs in diagnosis , 1991 .

[101]  A. Hughes,et al.  Symptomatic and silent gall stones in the community. , 1991, Gut.

[102]  A. Diehl.  Epidemiology and natural history of gallstone disease. , 1991, Gastroenterology clinics of North America.

[103]  E. Gibney,et al.  Asymptomatic gallstones , 1990, The British journal of surgery.

[104]  P Mouret,et al.  [Celioscopic surgery. Evolution or revolution?]. , 1990, Chirurgie; memoires de l'Academie de chirurgie.

[105]  H. Pitt,et al.  Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. , 1990, Surgery, gynecology & obstetrics.

[106]  A. Velardi,et al.  Gallstone prevalence and gallbladder volume in children and adolescents: an epidemiological ultrasonographic survey and relationship to body mass index. , 1989, The American journal of gastroenterology.

[107]  M. Sivak,et al.  Endoscopic management of bile duct stones. , 1989, American journal of surgery.

[108]  F. Bazzoli,et al.  Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. , 1989, Gastroenterology.

[109]  W. Willett,et al.  Weight, diet, and the risk of symptomatic gallstones in middle-aged women. , 1989, The New England journal of medicine.

[110]  R. Goldstein,et al.  Gallstone formation during weight-reduction dieting. , 1989, Archives of internal medicine.

[111]  A. Lowenfels,et al.  Gallstone growth, size, and risk of gallbladder cancer: an interracial study. , 1989, International journal of epidemiology.

[112]  M. Fava,et al.  Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area. , 1989, Gastroenterology.

[113]  L. Capocaccia,et al.  The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease , 2005 .

[114]  G. Paumgartner,et al.  Fragmentation of gallstones by extracorporeal shock waves. , 1986, Seminars in liver disease.

[115]  G. Bonorris,et al.  Effect of dietary cholesterol on biliary lipids in patients with gallstones and normal subjects. , 1985, The American journal of clinical nutrition.

[116]  A. Lowenfels,et al.  Gallstones and risk of gallbladder cancer. , 1985, Journal of the National Cancer Institute.

[117]  J. Amaral,et al.  Gallbladder disease in the morbidly obese. , 1985, American journal of surgery.

[118]  N. LaRusso,et al.  Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations. , 1985, The New England journal of medicine.

[119]  R. B. O'Gorman,et al.  Cholelithiasis and cholecystitis in childhood. , 1984, American journal of surgery.

[120]  P. Baghurst,et al.  Diet, alcohol, and relative weight in gall stone disease: a case-control study. , 1984, British medical journal.

[121]  Z. Halpern,et al.  An increased familial frequency of gallstones. , 1983, Gastroenterology.

[122]  G. Everson,et al.  A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction , 1980 .

[123]  Shehadi Wh.  The biliary system through the ages. , 1979 .

[124]  K. Hellström,et al.  The effect of cholesterol feeding on bile acid kinetics and biliary lipids in normolipidemic and hypertriglyceridemic subjects. , 1979, Journal of lipid research.

[125]  W. Shehadi.  The biliary system through the ages. , 1979, International surgery.

[126]  S. Grundy,et al.  Risk factors for the development of cholelithiasis in man (second of two parts). , 1978, The New England journal of medicine.

[127]  M. Carey.  Critical tables for calculating the cholesterol saturation of native bile. , 1978, Journal of lipid research.

[128]  Y. Adam,et al.  Calcified Gallbladder (Porcelain Gallbladder) , 1978 .

[129]  H. Shieh,et al.  Crystal structure of anhydrous cholesterol , 1977, Nature.

[130]  G. Leopold,et al.  Gray scale ultrasonic cholecystography: a comparison with conventional radiographic techniques. , 1976, Radiology.

[131]  B. Craven,et al.  Crystal structure of cholesterol monohydrate , 1976, Nature.

[132]  I. Makino,et al.  [Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid]. , 1975, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[133]  M. Olszewski,et al.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. , 1973, The Journal of clinical investigation.

[134]  W. Connor,et al.  The effect of dietary cholesterol on the composition of human bile. , 1973, Surgery.

[135]  J. Thistle,et al.  Dissolution of cholesterol gallstones by chenodeoxycholic acid. , 1972, The New England journal of medicine.

[136]  P. Bennett,et al.  Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography. , 1970, The New England journal of medicine.

[137]  D. Small,et al.  The physicochemical basis of cholesterol gallstone formation in man. , 1968, The Journal of clinical investigation.

[138]  S. Sherlock,et al.  Diseases of the Liver and Biliary System , 1955 .

[139]  G. Gordon‐Taylor.  On gall‐stones and their sufferers , 1937 .

[140]  C. Langenbuch.  Ein Fall von Exstirpation der Gallenblase wegen chronischer Cholelithiasis. Heilung , 1882 .

[141]  Wm. O. Dabney.  ART. XI—The Use of Choleate of Soda to prevent the formation of Gall-Stones , 1876 .